07:00 , May 25, 2015 |  BioCentury  |  Finance

Cash cravings

BioCentury's 13th annual European Iceberg survey foresees record financing demand, driven on the public side by higher burn rates and the number of companies joining the group via IPOs, and on the private side by...
07:00 , Apr 7, 2014 |  BC Week In Review  |  Financial News

NeuMoDx Molecular completes venture financing

NeuMoDx Molecular Inc. , Ann Arbor, Mich.   Business: Diagnostic   Date completed: 3/26/14   Type: Venture financing   Raised: $21 million   Investors: Pfizer Venture Investments; Baird Venture Partners; Venture Investors; Arboretum Ventures; Wolverine...
07:00 , Oct 7, 2013 |  BC Week In Review  |  Financial News

GenomeDx Biosciences completes venture financing

GenomeDx Biosciences Inc. , Vancouver, B.C.   Business: Diagnostic   Date completed: 9/30/13   Type: Venture financing   Raised: Not disclosed   Investors: Merck Global Health Innovation Fund; Baird Venture Partners; Aeris Capital AG; CD...
07:00 , Oct 7, 2013 |  BioCentury  |  Finance

Deciphering GenomeDx

Deciphering GenomeDx While some investors are fleeing the diagnostic space, a series B round for GenomeDx Biosciences Inc. shows there is money out there for companies with a path to reimbursement. The size of the...
00:47 , Oct 1, 2013 |  BC Extra  |  Financial News

GenomeDx closes series B round

Molecular diagnostic company GenomeDx Biosciences Inc. (Vancouver, B.C.) raised an undisclosed amount in a series B round led by new investor Merck Global Health Innovation Fund and a new undisclosed investor. Existing investors Baird Venture...
08:00 , Jan 16, 2012 |  BC Week In Review  |  Financial News

GenomeDx Biosciences completes venture financing

GenomeDx Biosciences Inc. , Vancouver, B.C.   Business: Diagnostic   Date completed: 1/10/12   Type: Venture financing   Raised: Not disclosed   Investors: Baird Venture Partners; Aeris Capital; CD Ventures; individual investors  ...
08:00 , Jan 16, 2012 |  BC Week In Review  |  Company News

GenomeDx Biosciences board of directors update

GenomeDx Biosciences Inc. , Vancouver, B.C.   Business: Diagnostic, Cancer   Appointed: Mike Liang, partner at Baird Venture Partners; and George Rehm, managing partner at Aeris Capital AG  ...
01:28 , Jan 11, 2012 |  BC Extra  |  Financial News

GenomeDx closes series A round

Molecular diagnostics company GenomeDx Biosciences Inc. (Vancouver, B.C.) raised an undisclosed amount in a series A round led by new investors Baird Venture Partners and Aeris Capital. New investor CD Ventures and a group of...
08:00 , Nov 10, 2008 |  BioCentury  |  Finance

The denominator effect

Some of the largest public pension funds, crushed by losses in the public equity markets, are being forced to either reassess how they allocate their investments or rebalance their portfolios in order to maintain mandated...
07:00 , Aug 25, 2008 |  BioCentury  |  Finance

Ebb & Flow

Genentech (NYSE:DNA) disclosed in an SEC filing last week details of the retention and severance plans it has put in place to cover “substantially all” of its employees and executives as the biotech negotiates over...